Fujita J, Yoshida O
Hinyokika Kiyo. 1984 Nov;30(11):1627-31.
The effects of an aromatic retinoic acid analog (Ro 10-9359), its metabolite (Ro 10-1670) and mitomycin C (MMC) on the in vitro growth of rat bladder carcinoma cells, BC50-TC were examined. The growth of the cells treated with 10(-4) M of either of the retinoids for 1 hour was not inhibited. The growth of the cells was inhibited by 37% and 93%, respectively, by the 3-day treatment with Ro 10-9359 and Ro 10-1670, at the concentration of 5 X 10(-5) M. The retinoids given in combination with MMC produced additive effects. Slight synergism was suggested at high concentrations of the retinoid. The fact that the retinoids exhibited anti-tumor activity in vitro might preclude indirect effects from being the only factor in the inhibition of the tumor growth in vivo, but the fact that antagonism with MMC did not occur in vitro whereas it did in vivo suggests that the indirect effects of the retinoid might be more important in mediating the anti-tumor effects. Regardless of the mechanism of action, care should be taken when prescribing retinoids with MMC or other cytotoxic agents.
研究了一种芳香维甲酸类似物(Ro 10-9359)、其代谢产物(Ro 10-1670)和丝裂霉素C(MMC)对大鼠膀胱癌细胞BC50-TC体外生长的影响。用10⁻⁴M的任何一种类维生素A处理细胞1小时,其生长均未受到抑制。在浓度为5×10⁻⁵M时,用Ro 10-9359和Ro 10-1670进行3天处理,细胞生长分别被抑制37%和93%。类维生素A与MMC联合使用产生相加作用。在高浓度类维生素A时显示出轻微的协同作用。类维生素A在体外表现出抗肿瘤活性这一事实可能排除了间接作用是体内抑制肿瘤生长的唯一因素,但类维生素A在体外未与MMC发生拮抗作用而在体内发生了拮抗作用这一事实表明,类维生素A的间接作用在介导抗肿瘤作用中可能更重要。无论作用机制如何,在开具类维生素A与MMC或其他细胞毒性药物的处方时都应谨慎。